biphasic human insulin 30

DRUG12 trials

Sponsors

Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy

Phase 1

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes

CompletedNCT00825253

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2007-03-31End: 2007-05-31Updated: 2017-01-06

Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects

CompletedNCT01486888

Novo Nordisk A/SDiabetes, Healthy

Start: 2006-05-31End: 2006-07-31Updated: 2015-03-18

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese

CompletedNCT01620450

Novo Nordisk A/SDiabetes, Healthy

Start: 2004-11-20End: 2005-02-26Updated: 2017-03-01

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers

CompletedNCT01707160

Novo Nordisk A/SDiabetes, Healthy

Start: 1995-11-30End: 1995-12-31Updated: 2017-01-04

Phase 2

Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes

CompletedNCT01526980

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2002-05-31End: 2002-11-30Updated: 2017-01-05

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

CompletedNCT01697618

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 1997-04-30End: 1998-11-30Updated: 2017-01-04

Phase 3

Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

CompletedNCT01520818

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2000-03-31End: 2001-04-30Updated: 2017-01-04

Phase 4

Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes

TerminatedNCT00799448

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2003-09-16End: 2004-09-20Updated: 2017-02-20

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

CompletedNCT00807092

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2008-12-31End: 2009-10-31Updated: 2015-03-04

Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes

CompletedNCT01487798

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2002-06-30End: 2003-11-30Updated: 2017-01-06

Unknown Phase

Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice

CompletedNCT01492166

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2006-11-30End: 2007-06-30Updated: 2016-12-13

Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction

CompletedNCT01492218

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2004-03-15End: 2004-08-30Updated: 2017-02-28

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01